Evidence map›Paper›PMID 37937729›Full record

ArticleCancer medicine2023

The clinical features and prognostic implications of PTPN11 mutation in adult patients with acute myeloid leukemia in China.

Jinjun Yang, Lei Zhao, Yu Wu, Ting Niu, Yuping Gong, Xinchuan Chen, Xiaoou Huang, Jiazhuo Liu, Yang Dai, Hongbing Ma

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. ConcurrentOncoTargets and therapy · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Jinjun YangDepartment of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0001-8998-8796
Lei ZhaoDepartment of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China.
Yu WuDepartment of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0001-8708-9711
Ting NiuDepartment of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China.
Yuping GongDepartment of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China.
Xinchuan ChenDepartment of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China.
Xiaoou HuangDepartment of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China.
Jiazhuo LiuDepartment of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China.
Yang DaiDepartment of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China.
Hongbing MaDepartment of Hematology and Institute of Hematology, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0002-1174-4078
Sichuan University · CN

Funding

1·3·5 project for disciplines of excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University 2022HXFH040
6 · The paper itself

Abstract

backgroundThe clinical significance of protein tyrosine phosphatase nonreceptor type 11 mutation (PTPN11

methodsWe collected the data of AML patients with mutated PTPN11 and wild-type PTPN11 (PTPN11

resultsFifty-nine PTPN11

conclusionPTPN11

Indexed as

Leukemia, Myeloid, AcuteNucleophosminAdultChinaHumansMutationPrognosisProtein Tyrosine Phosphatase, Non-Receptor Type 11NucleophosminProtein Tyrosine Phosphatase, Non-Receptor Type 11PTPN11 protein, humanacute myeloid leukemiaevent-free survivaloverall survivalPTPN11

Identifiers

PMID37937729
PMCPMC10726903
OpenAlexW4388491688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.